光明乳業(600597.SH):7.51億元競得江蘇輝山乳業及江蘇輝山牧業相關資產
格隆匯12月24日丨光明乳業(600597.SH)公佈,2019年12月23日至2019年12月24日,公司參與競拍輝山乳業發展(江蘇)有限公司(“江蘇輝山乳業”)及輝山牧業發展(江蘇)有限公司(“江蘇輝山牧業”)相關資產,並最終以人民幣約7.51億元的成交價格中標。
此次競拍為資產拍賣,原江蘇輝山乳業及江蘇輝山牧業的債權債務和或有負債與公司無關。
對公司影響:1、有利於公司增加奶牛存欄數,完善華東、華北地區奶源基地佈局。2、有利於公司繼續優化產能,完善華東、華北地區生產基地佈局。3、有利於公司拓展江蘇、山東、安徽等市場,進一步做大做強乳製品產業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.